NIKKI SIXX On MICK MARS's Allegation MÖTLEY CRÜE Doesn't Play Live: 'It's A Betrayal To The Band Who Saved His Life'

In a new interview with the Los Angeles Times, MÖTLEY CRÜE bassist Nikki Sixx spoke about Mick Mars's ongoing legal battle with the iconic hard rockers, after the guitarist alleged that the group was pushing him out after he announced his retirement from touring.

When Mars announced his retirement from touring with MÖTLEY CRÜE in October 2022 as a result of worsening health issues, he maintained that he would remain a member of the band, with John 5 taking his place on the road. Only six months later, however, he filed a lawsuit against MÖTLEY CRÜE in Los Angeles County's Superior Court, claiming that, after his announcement, the rest of CRÜE tried to remove him as a significant stakeholder in the group's corporation and business holdings via a shareholders' meeting.

"[Mick] came to us and said, health-wise, he couldn't fulfill his contract, and we let him out of the deal," Sixx told the Los Angeles Times. "Then he sued us because he just said that he can't tour. We were like, 'Well, if you can't tour, you can't tour.' I will probably come to that too someday."

Sixx also addressed Mars's allegation in his lawsuit that the guitarist was the only bandmember to play 100 percent live on MÖTLEY CRÜE's 2022 The Stadium Tour", claiming Nikki "did not play a single note on bass during the entire U.S. tour."

"Anything we enhance the shows with, we actually played," Sixx told the Los Angeles Times. "If there are background vocals with my background vocals, and we have background singers to make it sound more like the record. That does not mean we're not singing."

MÖTLEY CRÜE's attorney, Sasha Frid, wrote in a statement to the Los Angeles Times: "The fact of the matter is that MÖTLEY always plays live. Even Mars's expert witness in the litigation, who Mars hired and who reviewed hours of footage, agreed and said that the band played live while performing. He disputed Mars's own claims."

Sixx went on to call Mars's accusations a "crazy betrayal", adding: "Saying he played in a band that didn't play, it's a betrayal to the band who saved his life. People say things like, 'Well, if you guys are really playing, then I need isolated tracks from band rehearsal.' … It's ludicrous."

In response to Mars's lawsuit, CRÜE's manager of more than three decades, Allen Kovac, told Variety in a 2023 interview that Mars was coming out with a list of allegations "to gain leverage in a smear campaign on MÖTLEY. He's attacked the band, and he's done it in a slanderous way, with false accusations and misrepresenting the facts to the fans. Mick is not the victim. The victims are MÖTLEY CRÜE and the brand, which Mick is so prideful of." But, he added, "What's upsetting to me is not Mick, but his representatives, who have guided Mick to say and do harmful things to the brand he cares about so much, MÖTLEY CRÜE. He has a degenerative disease and people are taking advantage of him. It's called elder abuse."

Kovac continued: "Mick's representatives have no idea what they've created, but I've stopped the band from speaking about this, so they're not gonna turn the fans against Mick. But I am going to make sure that people understand that Mick hasn't been treated badly. In fact, he was treated better than anyone else in the band, and they carried him and they saved his life."

Mars suffers from Ankylosing Spondylitis (AS),a chronic and inflammatory form of arthritis that mainly affects the spine and pelvis. After years of performing through the pain, he informed the other members of MÖTLEY CRÜE in the summer of 2022 that he could no longer tour with them but would still be open to recording new music or performing at residencies that did not require much travel.

Regarding Mick's claim that he was the only CRÜE member to play 100 percent live on the 2022 recent tour, Kovac told Variety at the time: "Everything is live with Nikki's bass playing and Tommy's [Lee] drum playing. When they've used loops, they're still playing. There are augmented vocals, which were (recorded) in the studio and are backgrounds behind the two ladies who are singing and (other background vocals by) John 5 and Nikki Sixx, and before that Mick and Nikki." He described the pre-recorded vocal layering as where "you multi-track and you do gang vocals with, like, 20 people, just like all the other bands do with background vocals. They've got background vocals in the mix. That's the truth.

"But Nikki played his bass and always has," Kovac continued. "Vince [Neil] was singing better than he was before (on the 2022 tour). That was in reviews. Now, John 5 is playing like who John 5 is. I've heard John 5 perform and I heard Mick perform. Both are great guitar players. Unfortunately, Mick is not the same. He hasn't been the same for a long time. Which was in reviews! You see that the professionals knew. DEF LEPPARD (which alternated headlining spots on the tour) knew. And (Mars) caused a train wreck up there, because he would play the wrong songs and the wrong parts, even with the guide tracks. When he played the wrong song, it wasn't Nikki Sixx that had a tape; it was the soundman bringing it into the mix so the audience could hear a song, even though the guitar player was playing a different song." He says audiences "would hear it at first, but (sound engineers) would fix it so that we could keep the song going. I heard it. I'd go to the soundboard."

Mars — whose real name is Robert Alan Deal — served as MÖTLEY CRÜE's lead guitarist since the band's inception in 1981.

Although Sixx is responsible for penning the lion's share of the band's material, Mars did have a hand in co-writing some of the group's most famous tracks, including "Same Ol' Situation (S.O.S.)", "Girls, Girls, Girls" and "Dr. Feelgood".

The only credit Mars has on the first two MÖTLEY CRÜE albums is the instrumental "God Bless The Children Of The Beast" on 1983's "Shout At The Devil".

Mick's debut solo album, "The Other Side Of Mars", was released in February 2024 via his own label 1313, LLC, in partnership with MRI.